- Home
- J&J Innovative Medicine
J&J Innovative Medicine
5 questions for a scientist who’s working to uncover new treatments for psoriatic arthritis
Early in his career Daniel Cua, Ph.D., made a discovery that would lead to a new medication for the debilitating autoimmune disease. We sat down with Dr. Cua, known as “the father” in his field of study, to learn what his work could mean for those with psoriatic arthritis.
What you need to know about Johnson & Johnson’s 2020 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.
Johnson & Johnson and its partners mark a milestone in the quest for a global preventive HIV vaccine with the Imbokodo Study
The clinical trial has completed full immunizations of the company’s investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
“AIDS won’t stop for COVID-19": Meet 3 inspiring women who are as committed as ever to making HIV history
For World AIDS Day, three attendees of the virtual 2020 International AIDS Society Conference, including activist and actress Laverne Cox, talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.
6 latest facts about Johnson & Johnson’s Ebola vaccine
In response to a new Ebola outbreak in Guinea, Johnson & Johnson is providing up to 200,000 doses of its Ebola vaccine regimen to the country for a World Health Organization supported clinical trial. Learn more about the initiative and other top facts about the vaccine regimen for the deadly virus.
“What COVID-19 has taught me": 7 Johnson & Johnson researchers reveal lessons they’ve learned from the pandemic
From scientists working on a potential vaccine to medically trained employees who mobilized to the front lines to help treat patients, these men and women share what most resonates for them about the unique and devastating virus, both professionally and personally.
She’s a scientist with one of the world’s most important jobs: Creating a potential COVID-19 vaccine
Imagine being a researcher who is staring down not only a highly infectious virus, but one that’s caused the first global pandemic in more than 100 years. Meet Johnson & Johnson’s Hanneke Schuitemaker, Ph.D.
“I’m a scientist working on a potential COVID-19 vaccine”: Meet a researcher who’s studying a promising candidate
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
What you need to know about Johnson & Johnson’s 2020 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.
Can an Apple Watch reduce the likelihood of suffering a stroke? The innovative study that’s tackling the problem of AFib
Cardiologist C. Michael Gibson is heading up a virtual research study that uses wearable technology and cutting-edge apps to help detect atrial fibrillation, one of the biggest risk factors for stroke. We dive into how the study will work.